Page 210 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

2 MÉDICAMENTS DU DIABETE SUCRÉ UTILISABLES PAR VOIE ORALE 171

REITZ A.B. et TUMAN R.W., Carbohydrates biguanides as potential antidiabetic drugs
in New antidiabetic drugs (BAILEY C.J. &. FLATT P. R edit.) Smith-Gordon, London,
1990, 171-176.
Diacides à longues chaînes
BAR-TANA J. Long-chain dicarboxylic acids : hypolipidaemic, antiobesity and antidia­
betic activity, in New antidiabetic drugs (BAILEY C.J. &. FLATT P. R edit.), Smith-
Gordon, London, 1990, 157-162.
10-hydroxypyrimidino[l,2-a]indoles
CLIFFE LA., LIEN E.L., MANSELL H.L., STEINER K.E., TODD R.S., WHITE
A.C. & BLACK R.M. Oral hypoglycémie agents. Pyrimido[1,2-a]indoles and related
compounds. J. Med. Chem., 1992, 35,1169-1175.
Agonistes P3
TRISCARI J., TILLEY J. et HOGAN S., The pharmacological treatment of obesity,
Annuai Reports in Médicinal Chemistry, 1988, 23,191-200 Academie press.
ZAAGSMA J. et NAHORSKI R.S., Is the adipocyte p-adreno ceptor a prototype for the
recently cloned atypical "P3-adreno- ceptor" ? Trends in Pharmacol. Sci., 1990, 11,
3-7.
SMITH S.A. SENNITT M.V. et CAWTHORNE M.A., BRL 35 135 : an orally active anti-
hyperglycaemic agent with weight reducing effects in : New antidiabetic drugs
(BAILEY C.J. &. FLATT P. R edit.), Smith-Gordon, London, 1990, 177-189.
BLOOM J.D., DUTIA M.D., JOHNSON B.D., WISSNER A., BURNS M.G., LARGIS E.E.,
DOLAN J.A. et CLAUS H., Disodium (R,F?)-5-[2-[[2-(3-chlorophenyl)-2-hydroxye-
thyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316 243) A potent p-
adrenergic agonist virtually spécifie for p3 receptors. A promising antidiabetic and
antiobesity agent. J. Med. Chem. 1992, 35, 3081-3084.
CONNACHER A.A., BENNET WX.M. et JUNG R.T., Clinical studies in the beta-adre-
noceptor agonist BRL 26830A. Amer. J. Clin. Nutr. 1992, 55 (supp 1), S 258.
CONNACHER A.A., BENNET WX.M. et JUNG R.T., Metabolic effects of three weeks
admnistration of the beta-adrenoceptor agonist BRL 26830A. Int. J. Obesity., 1992,
16, 685.
BRL 26 830 A, Drugs ofthe Future, 1993, 18, 259-260.
Inhibiteurs de l'oxydation des acides gras
HO W., TUTWILER G.F., COTTRELL S.C., MORGANS D.J., TARHAN O. et
MOHRBACHER R.J., Alkylglycidic acids : potential new hypoglycémie agents.
J. Med. Chem. 1986, 29, 2184-2190.
SELBY P.L. et SHERATT H.S.A., Subsituted 2-oxiranecarboxilic acids : a new group
of candidate hypoglycaemic drugs, Trends in Pharmacol. Sci, 1989, 10, 495-500.
BAILEY C.J. et FLATT P.R., Alkylglycidates in New antidiabetic drugs (BAILEY C.J. &.
FLATT P. R edit.), Smith-Gordon, London, 1990, 231-236.
WOLF H.P.O., Aryl-substitued 2-oxirane carboxylic acids : a new group of antidiabetic
drugs, in : New antidiabetic drugs (BAILEY C.J. &. FLATT P. R edit.), Smith-Gordon,
London,1990, 217-229.
Etomoxir, Drugs ofthe Future, 1992, 16, 1132.